Cognitive Behavioral Therapy (CBT)

Treatment for Cocaine use disorders

Typical Dosage: 60-90 minute sessions, 1-2 times per week

Effectiveness
75%
Safety Score
95%
Clinical Trials
15
Participants
12K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
60-90 minute sessions, 1-2 times per week
Time to Effect
2-3 months
Treatment Duration
12-24 weeks
Evidence Quality
HIGH
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$400
Side Effect Mgmt:$0
Total Annual:$400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
0.4
Outcome-Based Costs
Cost per Responder
$6,545
Cost per Remission
$10,286
Cognitive Behavioral Therapy (CBT) Outcomes

for Cocaine use disorders

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+55%
Remission Rate
+35%
Common Side Effects
Temporary discomfort during sessions
+5%
Emotional fatigue
+2%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Cognitive Behavioral Therapy (CBT) in Cocaine use disorders

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

NCT07227948RECRUITINGPHASE2
View Study
75 participants
INTERVENTIONAL
Houston, United States
Started: Jan 15, 2026

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

NCT05974202NOT YET RECRUITINGNA
View Study
30 participants
INTERVENTIONAL
New York, United States
Started: May 1, 2026

Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder

NCT05833529RECRUITINGNA
View Study
54 participants
INTERVENTIONAL
Fort-de-France, Martinique +1 more
Started: May 1, 2023

Treating Polysubstance Use Using a Novel Digital Technology

NCT05766631RECRUITINGPHASE3
View Study
240 participants
INTERVENTIONAL
Baltimore, United States +4 more
Started: Jul 26, 2023
Completed Clinical Trials
8 completed trials for Cognitive Behavioral Therapy (CBT) in Cocaine use disorders

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

NCT04843046COMPLETEDPHASE2
View Study
61 participants
INTERVENTIONAL
Houston, United States
Started: Aug 23, 2021

Treatment Outcome in CBT for Cocaine Use

NCT03538548COMPLETEDNA
View Study
68 participants
INTERVENTIONAL
New York, United States
Started: Sep 30, 2014

Adaptive Treatment for Alcohol and Cocaine Dependence

NCT01032135COMPLETEDPHASE2, PHASE3
View Study
500 participants
INTERVENTIONAL
Philadelphia, United States +2 more
Started: Oct 1, 2008

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)

NCT02174614COMPLETEDPHASE1
View Study
99 participants
INTERVENTIONAL
Bridgeport, United States +1 more
Started: Apr 1, 2015

Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting

NCT03662529COMPLETEDNA
View Study
35 participants
INTERVENTIONAL
Richmond, United States
Started: Jun 5, 2017

Quetiapine for the Reduction of Cocaine Use

NCT00631748COMPLETEDNA
View Study
60 participants
INTERVENTIONAL
Tacoma, United States
Started: Feb 1, 2008

PPARγ Agonist Treatment for Cocaine Dependence

NCT02774343COMPLETEDPHASE1, PHASE2
View Study
30 participants
INTERVENTIONAL
Houston, United States
Started: Aug 1, 2012

Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users

NCT01614106COMPLETEDNA
View Study
360 participants
INTERVENTIONAL
Miami, United States +1 more
Started: Jan 1, 2013